Dutch data support continuation over discontinuation of urate-lowering therapy to achieve a serum urate level of 0.36 mmol/L ...
The European Alliance of Associations for Rheumatology - held its 2026 annual Congress in London, where gout was high on the ...
Crystalys Therapeutics has dosed the first patient with its once daily oral, URAT1 inhibitor dotinurad in its Phase II AMETHYST trial (NCT07535034), designed to assess dotinurad’s effectiveness in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results